Picard Medical, Inc. Research and Development Expense
Picard Medical, Inc. (PMI) reported Research and Development Expense of $1.37 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-19
- Picard Medical, Inc. research and development expense for the quarter ending 2026-06-30 was $1.37M, a 84.93% increase year-over-year.
- Picard Medical, Inc. research and development expense for the quarter ending 2026-03-31 was $1.90M, a 134.53% increase year-over-year.
- Picard Medical, Inc. research and development expense for the quarter ending 2025-12-31 was $547.00K, a 30.67% decline year-over-year.
- Picard Medical, Inc. research and development expense for the quarter ending 2025-09-30 was $951.00K, a 1.04% decline year-over-year.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.37M 10-Q · filed 2026-08-19 | $3.27M 10-Q · filed 2026-08-19 | $3.82M derived: sum of 3 quarters · filed 2026-08-19 | $4.77M derived: sum of 4 quarters · filed 2026-08-19 |
| 2026-03-31 | $1.90M 10-Q · filed 2026-05-15 | $2.44M derived: sum of 2 quarters · filed 2026-05-15 | $3.39M derived: sum of 3 quarters · filed 2026-05-15 | $4.14M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-12-31 | $547.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-05-01 | $1.50M derived: sum of 2 quarters · filed 2026-05-01 | $2.24M derived: sum of 3 quarters · filed 2026-08-19 | $3.05M S-1/A · filed 2026-05-01 |
| 2025-09-30 | $951.00K 10-Q · filed 2025-11-14 | $1.69M derived: sum of 2 quarters · filed 2026-08-19 | $2.50M 10-Q · filed 2025-11-14 | $3.29M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-06-30 | $743.00K 10-Q · filed 2026-08-19 | $1.55M 10-Q · filed 2026-08-19 | $2.34M derived: sum of 3 quarters · filed 2026-08-19 | $3.30M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-03-31 | $808.00K 10-Q · filed 2026-05-15 | $1.60M derived: sum of 2 quarters · filed 2026-05-15 | $2.56M derived: sum of 3 quarters · filed 2026-05-15 | $3.50M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $789.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-05-01 | $1.75M derived: sum of 2 quarters · filed 2026-05-01 | $2.69M derived: sum of 3 quarters · filed 2026-05-01 | $3.38M S-1/A · filed 2026-05-01 |
| 2024-09-30 | $961.00K 10-Q · filed 2025-11-14 | $1.90M derived: sum of 2 quarters · filed 2025-11-14 | $2.59M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $940.00K 10-Q · filed 2025-09-12 | $1.63M 10-Q · filed 2025-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |